We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy ... Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. Show more
false 0001829802 0001829802 2024-03-05 2024-03-05 0001829802 us-gaap:CommonStockMember 2024-03-05 2024-03-05 0001829802 us-gaap:SeriesAPreferredStockMember 2024-03-05 2024-03-05 ...
true false 0001829802 0001829802 2024-02-28 2024-02-28 0001829802 dei:FormerAddressMember 2024-02-28 2024-02-28 0001829802 us-gaap:CommonStockMember 2024-02-28 2024-02-28 0001829802...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
false 0001829802 0001829802 2024-02-05 2024-02-05 0001829802 us-gaap:CommonStockMember 2024-02-05 2024-02-05 0001829802 us-gaap:SeriesAPreferredStockMember 2024-02-05 2024-02-05 ...
false 0001829802 0001829802 2024-01-04 2024-01-04 0001829802 us-gaap:CommonStockMember 2024-01-04 2024-01-04 0001829802 us-gaap:SeriesAPreferredStockMember 2024-01-04 2024-01-04 ...
falsetrueQ30001829802--12-31P1Ytwo yearsthree yearsDecember 30, 20220001829802us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001829802snse:UnvestedRestrictedStockUnitsMember2022...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.02 | -1.8691588785 | 1.07 | 1.22 | 1.01 | 73866 | 1.12403726 | CS |
4 | 0.21 | 25 | 0.84 | 1.22 | 0.79 | 85258 | 0.98939505 | CS |
12 | 0.28 | 36.3636363636 | 0.77 | 1.22 | 0.71 | 53631 | 0.90275453 | CS |
26 | 0.2658 | 33.8944146901 | 0.7842 | 1.22 | 0.51 | 60793 | 0.78179296 | CS |
52 | -0.28 | -21.0526315789 | 1.33 | 1.926 | 0.51 | 54268 | 1.11342634 | CS |
156 | -12.02 | -91.9663351186 | 13.07 | 15.18 | 0.51 | 75088 | 4.87660968 | CS |
260 | -23.65 | -95.7489878543 | 24.7 | 26.38 | 0.51 | 86011 | 7.1286538 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions